These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32805187)

  • 21. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
    Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
    Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Na+/H+ exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure.
    Nakamura TY; Iwata Y; Arai Y; Komamura K; Wakabayashi S
    Circ Res; 2008 Oct; 103(8):891-9. PubMed ID: 18776042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of inward rectifier potassium current ionic channel remodeling by AT
    He J; Xu Y; Yang L; Xia G; Deng N; Yang Y; Tian Y; Fu Z; Huang Y
    Cell Biol Int; 2018 Sep; 42(9):1149-1159. PubMed ID: 29719087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis.
    Sarikhani M; Maity S; Mishra S; Jain A; Tamta AK; Ravi V; Kondapalli MS; Desingu PA; Khan D; Kumar S; Rao S; Inbaraj M; Pandit AS; Sundaresan NR
    J Biol Chem; 2018 Apr; 293(14):5281-5294. PubMed ID: 29440391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear localized protein-1 (Nulp1) increases cell death of human osteosarcoma cells and binds the X-linked inhibitor of apoptosis protein.
    Steen H; Lindholm D
    Biochem Biophys Res Commun; 2008 Feb; 366(2):432-7. PubMed ID: 18068114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canstatin suppresses isoproterenol-induced cardiac hypertrophy through inhibition of calcineurin/nuclear factor of activated T-cells pathway in rats.
    Sugiyama A; Okada M; Yamawaki H
    Eur J Pharmacol; 2020 Mar; 871():172849. PubMed ID: 31843516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy.
    Cai B; Tan X; Zhang Y; Li X; Wang X; Zhu J; Wang Y; Yang F; Wang B; Liu Y; Xu C; Pan Z; Wang N; Yang B; Lu Y
    Stem Cells Transl Med; 2015 Dec; 4(12):1425-35. PubMed ID: 26586774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of hypoxia-inducible factor-2 in adipocytes results in pathological cardiac hypertrophy.
    Lin Q; Huang Y; Booth CJ; Haase VH; Johnson RS; Celeste Simon M; Giordano FJ; Yun Z
    J Am Heart Assoc; 2013 Dec; 2(6):e000548. PubMed ID: 24326162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
    Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
    Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin.
    Jiang DS; Luo YX; Zhang R; Zhang XD; Chen HZ; Zhang Y; Chen K; Zhang SM; Fan GC; Liu PP; Liu DP; Li H
    Hypertension; 2014 Jan; 63(1):119-27. PubMed ID: 24144649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor.
    Tu VC; Sun H; Bowden GT; Chen QM
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1248-55. PubMed ID: 17108007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
    Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
    Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.
    Qian Q; Hu F; Yu W; Leng D; Li Y; Shi H; Deng D; Ding K; Liang C; Liu J
    J Am Heart Assoc; 2023 Apr; 12(7):e028628. PubMed ID: 36974751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. JIP3 deficiency attenuates cardiac hypertrophy by suppression of JNK pathway.
    Ma Q; Liu Y; Chen L
    Biochem Biophys Res Commun; 2018 Sep; 503(1):1-7. PubMed ID: 29604277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heat-shock transcription factor 1 is critically involved in the ischaemia-induced cardiac hypertrophy via JAK2/STAT3 pathway.
    Yuan L; Qiu L; Ye Y; Wu J; Wang S; Wang X; Zhou N; Zou Y
    J Cell Mol Med; 2018 Sep; 22(9):4292-4303. PubMed ID: 29992755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.